Reports
Reports
Sale
The global thoracic surgery market size was valued at USD 5 billion in 2023, driven by the improved use for minimally invasive procedures, increased number of CRM system replacements, and the increasing incidences of CVD and lung disease. The market is anticipated to grow at a CAGR of 9% during the forecast period 2024-2032 to reach a value of USD 10.8 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
A thoracic surgery involves any chest organ treatment or operation including the heart, lungs, oesophagus, as well as trachea. Thoracic surgery is also recognised as chest surgery. Thoracic surgery is conducted either by a minimally invasive procedure or by an open process. Thoracotomy requires chest incision and is used to treat lung cancer.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on product, the thoracic surgery market can be divided into:
Handheld surgical equipment can be further divided into forceps and spatulas, retractors, dilators, graspers, auxiliary instruments, and cutter instruments, among others.
The thoracic surgery market can be broadly categorised based on surgery type into:
It finds wide applications in the following sectors:
The EMR report looks into the regional thoracic surgery markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The growing demand for chest surgeries is motivated by factors, including an increased number of CRM system replacements, the increasing number of facilities for CRM implantation, and the increasing popularity of CVD and lung disease. The demand for thoracic surgery has also expanded among older patients and patients with serious co-morbidities, owing to technological progress in thoracic surgeries and the enhanced surgical experience and trust among high-risk individuals. The use of thorax surgery devices for various indications guidelines of several health organizations would further drive the demand from end-users for advanced thorax surgical devices. The growing number of thoracic operations will be a crucial development leading to the thoracic surgery market growth.
The report presents a detailed analysis of the following key players in the global thoracic surgery market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Thoracic Surgery Market Overview
3.1 Thoracic Surgery Market Historical Value (2017-2023)
3.2 Thoracic Surgery Market Forecast Value (2024-2032)
4 Global Thoracic Surgery Market Landscape
4.1 Thoracic Surgery: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Thoracic Surgery: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by End user
5 Global Thoracic Surgery Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Thoracic Surgery Market Segmentation
6.1 Thoracic Surgery Market by Product
6.1.1 Market Overview
6.1.2 Surgical Sutures and Staples
6.1.3 Handheld Surgical equipment
6.1.4 Electrosurgical Devices
6.2 Thoracic Surgery Market by End User
6.2.1 Market Overview
6.2.2 End User
6.2.3 Hospitals
6.2.4 Ambulatory Surgical Centers
6.2.5 Others
6.3 Thoracic Surgery Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Thoracic Surgery Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Thoracic Surgery Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Thoracic Surgery Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Thoracic Surgery Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Thoracic Surgery Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Partnership and Collaborations Analysis
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 Biosensors International Group
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 BIOTRONIK SE & Co.
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 BioVentrix, Inc.
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 C. R. Bard, Inc
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 CardiacAssist, Inc.
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 CircuLite Inc.
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 Johnson & Johnson
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 Corindus Vascular Robotics
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 Medtronic plc
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 Heartware International Inc.
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
19 Thoracic Surgery - Distribution Model (Additional Insight)
19.1 Overview
19.2 Potential Distributors
19.3 Key Parameters for Distribution Partner Assessment
20 Key Opinion Leaders (KOL) Insights (Additional Insight)
21 Company Competitiveness Analysis (Additional Insight)
21.1 Very Small Companies
21.2 Small Companies
21.3 Mid-Sized Companies
21.4 Large Companies
21.5 Very Large Companies
22 Payment Methods (Additional Insight)
22.1 Government Funded
22.2 Private Insurance
22.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The global thoracic surgery market reached a value of USD 5 billion in 2023.
The market is anticipated to grow at a CAGR of 9% during the forecast period of 2024-2032 to reach a value of USD 10.8 billion by 2032.
The major drivers of the industry, such as the improved use for minimally invasive procedures, increased number of CRM system replacements, the increasing number of facilities for CRM implantation, and the increasing incidences of CVD and lung disease, are expected to aid the market growth.
The key market trend guiding the growth of the market includes the growing use of thorax surgery devices for various indication guidelines of several health organizations.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major products of thoracic surgery in the industry are surgical sutures and staples, handheld surgical equipment, and electrosurgical devices.
The significant surgery types of thoracic surgery in the market are lobectomy, wedge resection, pneumonectomy, and pleurectomy, among others.
The major application sectors of the industry are oesophageal cancer and gastroesophageal reflux, among others.
The major players in the industry are AbbVie Inc., Boston Scientific Corp., Edwards Lifesciences Corp., LivaNova Plc, and Medtronic Plc, among others.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.